title: Are cyclooxygenase 2 inhibitors free of gastrointestinal side effects?
authors.affiliation: Department of Medicine, Guy's, King's, St Thomas' Medical School, Bessemer Rd, London SE5 9PJ, UK. ingvar.bjarnason@kcl.ac.uk
authors.forename: I
authors.initials: I
authors.lastname: Bjarnason
authors.forename: K D
authors.initials: KD
authors.lastname: Rainsford
mesh_terms: D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D005773:Gastroscopy; D006801:Humans; D007527:Isoenzymes / Q000494:pharmacology; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases / Q000494:pharmacology; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013276:Stomach Ulcer / Q000139:chemically induced / Q000175:diagnosis
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases